Camillo Passera

Recent publications · Crossref

5 total works indexed

1. Sorafenib in Advanced Hepatocellular Carcinoma

   · 2008 · cited 11,128x

2. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

   · 2024 · cited 4,085x

3. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

   · 2018 · cited 3,963x

4. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

   · 2008 · cited 2,531x

5. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

   · 2024 · cited 2,329x

via Crossref · CC0